The global high blood pressure/hypertension drugs monitoring device market is anticipated to grow at a considerable CAGR of 5.8% during the forecast period (2021-2027). The market growth is mainly attributed to the increasing number of people leading a hectic lifestyle and rise in geriatric population across the globe. Sedentary lifestyle has resulted in increased consumption of alcohol and smoking, particularly in developed economies. Increase in importance of blood pressure monitoring devices in home care settings and emergence of advanced technologies have also contributed significantly towards the growth of the market. Moreover, the increase in obese population and improvement in awareness about the harmful effects of hypertension have fuelled the market growth. However, lack of awareness about these devices in the low- and middle-income countries is use to hamper the market growth.
To Request a Sample of our Report on High Blood Pressure/Hypertension Drugs: https://www.omrglobal.com/request-sample/hypertension-drugs-monitoring-device-market
Furthermore, the mortality rate associated with non-communicable diseases including cardiovascular disease, cancer, diabetes, and chronic lung diseases have surpassed that of infectious diseases. According to a report by WHO in 2018, about 17 million deaths are caused due to cardiovascular diseases every year, of which hypertension accounts for about 45% of the fatalities, with nearly 9.4 million deaths. Developed countries such as the US and Germany have been able to control the incidence of hypertension in recent years through implementation of strong public health policies. However, a large pool of individuals in economically weak countries suffer from heart attacks and strokes due to uncontrolled hypertension.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
Segment Covered-
- By Drugs
- By Monitoring Devices
- By End-user
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Competitive Landscape- Hill-Rom Holdings, Inc., American Diagnostic Corporation, Boehringer Ingelheim International GmbH, Bayer AG, Koninklijke Philips N.V., GE Healthcare
(Get 15% Discount on Buying this Report)
A full Report of High Blood Pressure/Hypertension Drugs is Available at: https://www.omrglobal.com/industry-reports/hypertension-drugs-monitoring-device-market
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How COVID-19 impacted the market?
Ø Deviation from the pre-COVID-19 forecast
Ø Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global High Blood Pressure/Hypertension Drugs and Monitoring Device Market Report Segment
By Drugs
- Pulmonary Hypertension Drugs
- Systemic Hypertension Drugs
By Monitoring Devices
- Aneroid Sphygmomanometers
- Mercury Sphygmomanometer
- Digital Devices
- Ambulatory BP Monitors
By End-user
- Hospitals and Clinics
- Homecare
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
